Illumina PT Raised to $190.00 at Bank of America (ILMN)
Equities researchers at Bank of America increased their target price on shares of Illumina (NASDAQ:ILMN) from $165.00 to $190.00 in a research report issued on Tuesday, Analyst Ratings Network reports. Bank of America’s target price would suggest a potential upside of 15.62% from the company’s current price.
In other Illumina news, CEO Jay Flatley sold 30,000 shares of Illumina stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $160.43, for a total value of $4,812,900.00. Following the completion of the transaction, the chief executive officer now directly owns 385,105 shares in the company, valued at approximately $61,782,395. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Illumina (NASDAQ:ILMN) opened at 164.33 on Tuesday. Illumina has a one year low of $48.00 and a one year high of $165.45. The stock has a 50-day moving average of $135.5 and a 200-day moving average of $99.40. The company has a market cap of $20.822 billion and a price-to-earnings ratio of 181.97.
Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, January 28th. The company reported $0.45 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The company’s quarterly revenue was up 25.1% on a year-over-year basis. On average, analysts predict that Illumina will post $2.06 earnings per share for the current fiscal year.
ILMN has been the subject of a number of other recent research reports. Analysts at Leerink Swann set a $160.00 price target on shares of Illumina in a research note on Wednesday, January 29th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $150.00 to $175.00 in a research note on Wednesday, January 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note on Wednesday, January 29th. They now have a “neutral” rating on the stock. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Illumina presently has an average rating of “Hold” and a consensus target price of $118.71.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.